Elsevier

The Lancet

Volume 321, Issue 8318, 29 January 1983, Page 236
The Lancet

Letters to the Editor
ISOTRETINOIN-PUVA FOR PSORIASIS

https://doi.org/10.1016/S0140-6736(83)92607-7Get rights and content

References (3)

There are more references available in the full text version of this article.

Cited by (54)

  • Nonstandard and off-label therapies for psoriasis

    2008, Clinics in Dermatology
    Citation Excerpt :

    Etretinate (the prodrug of acitretin) has been shown to control plaque psoriasis more effectively than isotretinoin when used as a single agent.15 When the retinoids are combined with psoralen photochemotherapy, however, isotretinoin shows equal efficacy in psoriasis as etretinate.16 Because the half-life elimination of isotretinoin is significantly less than that of acitretin (because of conversion of acitretin to etretinate in vivo), psoralen photochemotherapy with isotretinoin can be an option for women of child-bearing age who do not wish to be on long-term contraception.

  • Retinoid therapy for psoriasis

    2004, Dermatologic Clinics
  • Phototherapy and photochemotherapy

    2004, Actas Dermo-Sifiliograficas
  • Treatment of psoriasis. Part 2. Systemic therapies

    2001, Journal of the American Academy of Dermatology
  • Proceedings of the psoriasis combination and rotation therapy conference

    1996, Journal of the American Academy of Dermatology
View all citing articles on Scopus
View full text